Skip to content
ppharmaranks
Menu

Azole antifungals compared

Compare all 20 azole antifungals side by side, used for conditions such as candidiasis, cutaneous, candidiasis, oral, candidiasis, vulvovaginal. Azole antifungals are the Azole Antifungal class. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores. The highest-rated is clotrimazole.

11 of 20 drugs in this class carry a pharmaranks safety score, ranging 56–72 out of 100 — computed from FDA recall records, not from reviews.

Rated against independent sources·Last updated June 7, 2026·How we rate

Top-rated azole antifungal: 1. Clotrimazole · 2. Ketoconazole · 3. Monistat 3

Azole Antifungal drugs compared side by side, with pharmaranks' FDA recall-safety rating
DrugGenericSafety ratingFDA recall-based
Clotrimazole—72/100
Ketoconazole—72/100
Monistat 3Miconazole Nitrate72/100
Monistat 3 Combination PackMiconazole Nitrate72/100
Monistat 7Miconazole Nitrate72/100
Monistat 7 Combination PackMiconazole Nitrate72/100
TolsuraItraconazole72/100
Voriconazole—72/100
Nizoral Anti-DandruffKetoconazole70/100
VfendVoriconazole60/100
DiflucanFluconazole56/100
CloticClotrimazoleNot yet rated

The safety rating column is unique to pharmaranks — an independent 0–100 score from FDA regulatory recall data. Higher is safer. Not medical advice.

Full ranking · 20 drugs

  1. 1

    clotrimazole

    Clotrimazole

    72/100
  2. 2

    ketoconazole

    Ketoconazole

    72/100
  3. 3

    monistat 3

    Miconazole Nitrate

    72/100
  4. 4

    monistat 3 combination pack

    Miconazole Nitrate

    72/100
  5. 5

    monistat 7

    Miconazole Nitrate

    72/100
  6. 6

    monistat 7 combination pack

    Miconazole Nitrate

    72/100
  7. 7

    tolsura

    Itraconazole

    72/100
  8. 8

    voriconazole

    Voriconazole

    72/100
  9. 9

    nizoral anti-dandruff

    Ketoconazole

    70/100
  10. 10

    vfend

    Voriconazole

    60/100
  11. 11

    diflucan

    Fluconazole

    56/100
  12. 12

    clotic

    Clotrimazole

    New
  13. 13

    ecoza

    Econazole Nitrate

    New
  14. 14

    exelderm

    Sulconazole Nitrate

    New
  15. 15

    lotrimin af

    Clotrimazole

    New
  16. 16

    mycelex

    Clotrimazole

    New
  17. 17

    oravig

    Miconazole

    New
  18. 18

    trivagizole 3

    Clotrimazole

    New
  19. 19

    vagistat-1

    Tioconazole

    New
  20. 20

    vivjoa

    Oteseconazole

    New

Frequently asked questions

What is the Azole Antifungal drug class?

Azole Antifungal is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 20 Azole Antifungal products, each independently rated.

Are all Azole Antifungal drugs the same?

No. Azole Antifungal drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.

Is "azole antifungals" the same as the Azole Antifungal class?

Yes — "azole antifungals" is the everyday name for the Azole Antifungal drug class. This page compares the 20 azole antifungals pharmaranks rates, with our independent FDA recall-safety score for each.

What conditions do Azole Antifungal drugs treat?

Per NIH RxClass drug-classification data, Azole Antifungal drugs are used for conditions including candidiasis, cutaneous, candidiasis, oral, candidiasis, vulvovaginal, tinea pedis, blastomycosis, candidiasis, chronic mucocutaneous.

Which Azole Antifungal drug is best-rated?

By our independent rating, clotrimazole currently ranks highest among Azole Antifungal drugs. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.

Sources: the Azole Antifungal class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class); how the class works is summarized from Antifungal Ergosterol Synthesis Inhibitors — StatPearls, NCBI Bookshelf (NIH). Ratings are pharmaranks’ independent FDA recall-safety analysis.